<DOC>
	<DOCNO>NCT01301222</DOCNO>
	<brief_summary>This randomize control trial ( RCT ) aim assess influence octreotide pancreatic fistula complication follow pancreatoduodenectomy patient soft pancreas . Previously report trial include type pancreatic resection include type pancreas show clearcut benefit octreotide pancreaticoduodenectomy ( PD ) . Soft pancreas normal sized duct risk factor fistula follow PD . This study 's focus select group patient aim assess role octreotide patient soft pancreas .</brief_summary>
	<brief_title>Role Octreotide Preventing Pancreatic Fistula After Pancreaticoduodenectomy ( PD ) Patients With Soft Pancreas</brief_title>
	<detailed_description>Study design : Prospective open label randomized trial . AIM : Study aim assess influence octreotide pancreatic fistula complication follow pancreatoduodenectomy patient soft pancreas .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Pancreatic Fistula</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>elective surgery patient undergo pancreatoduodenectomy soft pancreas , dilate duct age &gt; 75 year old document chronic pancreatitis previous pancreatic surgery previous gastric surgery vagotomy document pancreatic duct dilatation</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>octreotide</keyword>
	<keyword>pancreatic fistula</keyword>
	<keyword>soft pancreas</keyword>
	<keyword>pancreatoduodenectomy</keyword>
</DOC>